Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, April 21, 2010

Multicenter Prospective Study on Efficacy and Safety of Octreotide for Inoperable Malignant Bowel Obstruction

Note: Octreotide(brand name Sandostatin)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.